---
document_datetime: 2023-09-21 19:17:57
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/dynastat-epar-all-authorised-presentations_en.pdf
document_name: dynastat-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 1.0959345
conversion_datetime: 2025-12-20 08:34:28.875242
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical form                           | Route of administration          | Immediate Packaging                           | Content (concentration)     | Pack size            |
|------------------|-------------------|------------|-----------------------------------------------|----------------------------------|-----------------------------------------------|-----------------------------|----------------------|
| EU/1/02/209/0 05 | Dynastat          | 40 mg      | Powder for solution for injection             | Intravenous or intramuscular use | Vial (glass)                                  | 40 mg                       | 10 vials             |
| EU/1/02/209/0 06 | Dynastat          | 40 mg      | Powder and solvent for solution for injection | Intravenous or intramuscular use | Powder: vial (glass) Solvent: ampoule (glass) | Powder: 40 mg Solvent: 2 ml | 1 vial + 1 ampoule   |
| EU/1/02/209/0 07 | Dynastat          | 40 mg      | Powder and solvent for solution for injection | Intravenous or intramuscular use | Powder: vial (glass) Solvent: ampoule (glass) | Powder: 40 mg Solvent: 2 ml | 3 vials + 3 ampoules |
| EU/1/02/209/0 08 | Dynastat          | 40 mg      | Powder and solvent for solution for injection | Intravenous or intramuscular use | Powder: vial (glass) Solvent: ampoule (glass) | Powder: 40 mg Solvent: 2 ml | 5 vials + 5 ampoules |